KEGG   DRUG: Carbidopa hydrate and levodopa
Entry
D00253            Mixture   Drug                                   

Name
Carbidopa hydrate and levodopa;
Parcopa (TN);
Sinemet (TN)
Product
  Generic
CARBIDOPA AND LEVODOPA (A-S Medication Solutions), CARBIDOPA AND LEVODOPA (Accord Healthcare), CARBIDOPA AND LEVODOPA (Actavis Pharma), CARBIDOPA AND LEVODOPA (Alembic Pharmaceuticals), CARBIDOPA AND LEVODOPA (Alembic Pharmaceuticals Limited), CARBIDOPA AND LEVODOPA (American Health Packaging), CARBIDOPA AND LEVODOPA (American Health Packaging), CARBIDOPA AND LEVODOPA (Aphena Pharma Solutions - Tennessee), CARBIDOPA AND LEVODOPA (Aphena Pharma Solutions - Tennessee), CARBIDOPA AND LEVODOPA (Aphena Pharma Solutions - Tennessee), CARBIDOPA AND LEVODOPA (Aphena Pharma Solutions - Tennessee), CARBIDOPA AND LEVODOPA (BluePoint Laboratories), CARBIDOPA AND LEVODOPA (Cardinal Health), CARBIDOPA AND LEVODOPA (Cardinal Health), CARBIDOPA AND LEVODOPA (Golden State Medical Supply), CARBIDOPA AND LEVODOPA (Golden State Medical Supply), CARBIDOPA AND LEVODOPA (Major Pharmaceuticals), CARBIDOPA AND LEVODOPA (Mayne Pharma), CARBIDOPA AND LEVODOPA (Mayne Pharma), CARBIDOPA AND LEVODOPA (McKesson Corporation dba RX Pak), CARBIDOPA AND LEVODOPA (McKesson Corporation dba SKY Packaging), CARBIDOPA AND LEVODOPA (McKesson Corporation dba SKY Packaging), CARBIDOPA AND LEVODOPA (McKesson Corporation dba SKY Packaging), CARBIDOPA AND LEVODOPA (McKesson Corporation dba SKY Packaging), CARBIDOPA AND LEVODOPA (Mylan Institutional), CARBIDOPA AND LEVODOPA (Mylan Institutional), CARBIDOPA AND LEVODOPA (Mylan Pharmaceuticals), CARBIDOPA AND LEVODOPA (Mylan Pharmaceuticals), CARBIDOPA AND LEVODOPA (Mylan Pharmaceuticals), CARBIDOPA AND LEVODOPA (NCS HealthCare of KY), CARBIDOPA AND LEVODOPA (NuCare Pharmaceuticals), CARBIDOPA AND LEVODOPA (Sun Pharmaceutical Industries), CARBIDOPA AND LEVODOPA (Sun Pharmaceutical Industries), CARBIDOPA AND LEVODOPA (Sun Pharmaceutical Industries)
Component
Carbidopa [DR:D00558], Levodopa [DR:D00059]
Class
Neuropsychiatric agent
 DG01967  Antiparkinson agent
Remark
Therapeutic category: 1169
ATC code: N04BA02
Product: D00253<JP/US>
Efficacy
Antiparkinsonian
  Disease
Parkinson disease [DS:H00057]
Parkinsonism [DS:H01600]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N04 ANTI-PARKINSON DRUGS
   N04B DOPAMINERGIC AGENTS
    N04BA Dopa and dopa derivatives
     N04BA02 Levodopa and decarboxylase inhibitor
      D00253  Carbidopa hydrate and levodopa <JP/US>
USP drug classification [BR:br08302]
 Antiparkinson Agents
  Dopamine Precursors and/or L-Amino Acid Decarboxylase Inhibitors
   Carbidopa/ Levodopa
    D00253  Carbidopa hydrate and levodopa
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   116  Antiparkinsonian agents
    1169  Others
     D00253  Carbidopa hydrate and levodopa
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D00253
Other DBs
PubChem: 7847319
LigandBox: D00253
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system